Study finds aflibercept 8 mg supports 16 weeks intervals for PCV
December 18, 2025

Study Finds Comparable PCV Outcomes with Aflibercept 8 mg at Longer Intervals

Fewer injections, same outcomes? New PULSAR data suggest durability may be catching up in PCV.  In retina care, durability has…

APVRS 25   Article Thumb Day 2 1
December 13, 2025

When Retina Meets Glaucoma at APVRS 2025

When glaucoma complicates the retina, the rulebook gets rewritten. Here’s how the experts adapt.  On Day 2 of the 18th…

Discover our fascinating content at issuu

explore